度伐利尤单抗用于广泛期小细胞肺癌一线治疗的药物经济学研究系统评价
刘成裕, 覃方, 刘卢路, 张翠翠, 谢瑞杰, 刘代华
Pharmacoeconomic evaluations of durvalumab as a first-line treatment for extensive-stage small cell lung cancer： a systematic review
LIU Chengyu, QIN Fang, LIU Lulu, ZHANG Cuicui, XIE Ruijie, LIU Daihua
中国医院药学杂志
.
2024, (21): 2523
-2528
.
DOI: 10.13286/j.1001-5213.2024.21.14
